Fed­er­al bank­rupt­cy judge ap­proves Pur­due Phar­ma and Sack­ler­s' $6 bil­lion opi­oid set­tle­ment

A US bank­rupt­cy judge on Wednes­day ap­proved Pur­due Phar­ma’s set­tle­ment plan that will see the Sack­lers pay up to $6 bil­lion to states and vic­tims of ad­dic­tion for their role in the opi­oid epi­dem­ic — which is a bil­lion more than a pre­vi­ous set­tle­ment that was tossed out in De­cem­ber.

The Sack­ler fam­i­ly, who owns Pur­due Phar­ma, will pay be­tween $5.5 bil­lion and $6 bil­lion over 18 years, ac­cord­ing to a re­cent state­ment from Con­necti­cut At­tor­ney Gen­er­al William Tong. And while the plan would put an end to civ­il claims against the fam­i­ly over Pur­due’s in­volve­ment in the opi­oid epi­dem­ic, it does not re­lease them from fu­ture crim­i­nal li­a­bil­i­ty.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER